GAI
General American Investors Portfolio holdings
AUM $1.49B
1-Year Return
23.66%
This Quarter Return
+4.83%
1 Year Return
+23.66%
3 Year Return
+106.94%
5 Year Return
+191.29%
10 Year Return
+399.09%
AUM
$1.05B
AUM Growth
+$65.9M
(+6.7%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
36.9%
Holding
63
New
5
Increased
8
Reduced
16
Closed
–
Top Buys
| 1 |
Walmart
WMT
|
+$15.6M |
| 2 |
Oracle
ORCL
|
+$11.1M |
| 3 |
Broadcom
AVGO
|
+$5.82M |
| 4 |
KIN
Kindred Biosciences, Inc.
KIN
|
+$5.23M |
| 5 |
AXIS Capital
AXS
|
+$3.3M |
Top Sells
| 1 |
CVS Health
CVS
|
+$5.47M |
| 2 |
Diageo
DEO
|
+$4.72M |
| 3 |
American Express
AXP
|
+$4.52M |
| 4 |
Pfizer
PFE
|
+$2.86M |
| 5 |
MetLife
MET
|
+$2.54M |
Sector Composition
| 1 | Financials | 21.47% |
| 2 | Technology | 19.38% |
| 3 | Consumer Discretionary | 16.62% |
| 4 | Industrials | 12.34% |
| 5 | Healthcare | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Broadcom
AVGO
$1.7T
| $5.82M | 0.55% |
+240,000
| New | +$5.82M |
|
52
Charter Communications
CHTR
$35.7B
| $5.45M | 0.52% |
15,000
-5,000
| -25% | -$1.82M |
|
|
PETX
53
DELISTED
Aratana Therapeutics, Inc.
PETX
| $5.32M | 0.5% |
867,600
+248,940
| +40% | +$1.53M |
|
|
KIN
54
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.23M | 0.5% |
+666,467
| New | +$5.23M |
|
55
Adams Diversified Equity Fund
ADX
$2.65B
| $2.87M | 0.27% |
188,819
| – | – |
|
56
Royce Value Trust
RVT
$1.92B
| $2.83M | 0.27% |
179,416
-20,501
| -10% | -$324K |
|
57
Invesco S&P 500 Equal Weight ETF
RSP
$74.3B
| $2.69M | 0.25% |
+28,111
| New | +$2.69M |
|
58
Brighthouse Financial
BHF
$2.68B
| $2.21M | 0.21% |
+36,363
| New | +$2.21M |
|
|
APDNW
59
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
| $197K | 0.02% |
281,409
| – | – |
|
|
RPRX
60
DELISTED
Repros Therapeutics Inc.
RPRX
| $76K | 0.01% |
237,504
-282,325
| -54% | -$90.3K |
|